Beta-lactam + beta-lactamase inhibitor antibiotic
Pregnancy: Use with caution — amoxicillin is safe; clavulanate data limited. Avoid in threatened preterm labour (possible NEC association in neonates).
Co-amoxiclav 625mg (Augmentin)
Brand names: Augmentin
Adult dose
Dose: 625 mg (amoxicillin 500mg / clavulanate 125mg) three times daily for 5–7 days
Route: Oral
Frequency: Three times daily
Max: 625 mg TDS (standard ENT); 1 g TDS in severe infections
ENT indications: acute otitis media (treatment failure after amoxicillin 48–72 hours), acute rhinosinusitis with systemic features, peritonsillar abscess (alongside drainage), dental-origin ENT infections. Take with food to reduce GI side effects. Cover for H. influenzae and M. catarrhalis (beta-lactamase producers) that amoxicillin fails against.
Paediatric dose
Dose: 40 mg/kg
Route: Oral
Frequency: Three times daily
Max: 625 mg/dose
Concentration: 125 mg/ml
Oral suspension: 125/31 (125mg amoxicillin/31.25mg clavulanate per 5mL) or 250/62. Standard dose: 40 mg/kg/day (amoxicillin component) in 3 divided doses. High dose for resistant AOM: 90 mg/kg/day. Age <3 months: specialist advice. Take with food.
Dose adjustments
Renal
eGFR 10–30: 375 mg (250/125) every 12 hours. eGFR <10: avoid or use under specialist guidance.
Hepatic
Use with caution in hepatic impairment — hepatotoxicity risk (monitor LFTs). Avoid if history of co-amoxiclav-related cholestatic jaundice.
Paediatric weight-based calculator
Oral suspension: 125/31 (125mg amoxicillin/31.25mg clavulanate per 5mL) or 250/62. Standard dose: 40 mg/kg/day (amoxicillin component) in 3 divided doses. High dose for resistant AOM: 90 mg/kg/day. Age <3 months: specialist advice. Take with food.
Clinical pearls
- First-line treatment failure antibiotic for AOM when initial amoxicillin has failed (covers beta-lactamase producers)
- GI side effects are significantly higher than amoxicillin due to clavulanate — take with food, probiotic may help
- Cholestatic hepatitis risk increases with longer courses and in elderly — warn patients to report jaundice
- If penicillin-allergic: doxycycline or clarithromycin are alternatives for ENT infections
- For AOM with effusion alone (glue ear): antibiotics not indicated — watchful waiting
Contraindications
- Penicillin hypersensitivity
- Previous co-amoxiclav-associated cholestatic jaundice or hepatic dysfunction
- Infectious mononucleosis (rash risk)
Side effects
- Diarrhoea (common — clavulanate related)
- Nausea and vomiting
- Rash (maculopapular)
- Cholestatic jaundice / hepatitis (rare but well-recognised — more than amoxicillin alone)
- Oral/vaginal candidiasis
- Clostridium difficile colitis (uncommon)
Interactions
- Warfarin — may increase INR (monitor closely)
- Methotrexate — reduced renal excretion of methotrexate
- Oral contraceptives — theoretical reduction in efficacy (advise barrier method)
Monitoring
- Clinical response at 48–72 hours
- LFTs if prolonged course or prior hepatic history
Reference: BNFc; BNF; NICE NG98 AOM; NICE NG120 Sinusitis; PHE Antibiotic Guidelines. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- SMART Risk Score for Recurrent CVD · Cardiovascular Risk
- MAGGIC Heart Failure Risk Score · Heart Failure
- Long QT Syndrome (Schwartz Score) · Channelopathy / Sudden Cardiac Death
- PCSK9 Inhibitor Eligibility Assessment · Lipid Management
- C-Peptide to Glucose Ratio · Diabetes Classification
- Centor / McIsaac Score for Strep Pharyngitis · Throat
Pathways
- Adult Upper Airway Obstruction (Stridor) · DAS 2015 unanticipated difficult airway; RCEM
- Epistaxis Management · ENT-UK / NICE
- Acute Otitis Media · NICE NG91 2018
- Tonsillitis and Sore Throat · NICE NG84 2018
- Benign Paroxysmal Positional Vertigo · NICE CG124 / AAO-HNS Guidelines
- Acute Rhinosinusitis · NICE NG79 2017 / EPOS 2020